Manal H. El‐Sayed

7.9k total citations
88 papers, 2.1k citations indexed

About

Manal H. El‐Sayed is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Manal H. El‐Sayed has authored 88 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Epidemiology, 64 papers in Hepatology and 10 papers in Infectious Diseases. Recurrent topics in Manal H. El‐Sayed's work include Hepatitis C virus research (60 papers), Liver Disease Diagnosis and Treatment (55 papers) and Hepatitis B Virus Studies (48 papers). Manal H. El‐Sayed is often cited by papers focused on Hepatitis C virus research (60 papers), Liver Disease Diagnosis and Treatment (55 papers) and Hepatitis B Virus Studies (48 papers). Manal H. El‐Sayed collaborates with scholars based in Egypt, United States and United Kingdom. Manal H. El‐Sayed's co-authors include Amin K. El-Kharbotly, Nahid Afia, Mohsen Saleh Elalfy, Gamal Esmat, Homie Razavi, Imam Waked, Jeffrey V. Lazarus, Mohamed Hassany, Wahid Doss and Wafaa Elakel and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Manal H. El‐Sayed

80 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manal H. El‐Sayed Egypt 22 1.3k 1.3k 247 191 133 88 2.1k
Christopher O’Brien United States 26 927 0.7× 860 0.7× 326 1.3× 76 0.4× 251 1.9× 70 2.8k
Silvia Gaiani Italy 23 773 0.6× 751 0.6× 31 0.1× 20 0.1× 9 0.1× 69 1.7k
Andrew Jack United States 15 361 0.3× 499 0.4× 15 0.1× 81 0.4× 11 0.1× 58 1.0k
Amir Qamar United States 16 437 0.3× 1.5k 1.2× 95 0.4× 1.6k 8.1× 85 0.6× 42 2.6k
María E. Mayorga United States 29 112 0.1× 359 0.3× 36 0.1× 226 1.2× 121 0.9× 107 2.6k
David Krause United States 23 456 0.3× 800 0.6× 43 0.2× 763 4.0× 12 0.1× 39 1.7k
Johan Wallin Sweden 23 131 0.1× 384 0.3× 157 0.6× 231 1.2× 19 0.1× 84 2.6k
Giovanni Vizzini Italy 29 2.1k 1.6× 1.7k 1.3× 24 0.1× 67 0.4× 15 0.1× 89 2.7k
Ashish Garg India 16 130 0.1× 289 0.2× 41 0.2× 80 0.4× 57 0.4× 77 1.6k

Countries citing papers authored by Manal H. El‐Sayed

Since Specialization
Citations

This map shows the geographic impact of Manal H. El‐Sayed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manal H. El‐Sayed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manal H. El‐Sayed more than expected).

Fields of papers citing papers by Manal H. El‐Sayed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manal H. El‐Sayed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manal H. El‐Sayed. The network helps show where Manal H. El‐Sayed may publish in the future.

Co-authorship network of co-authors of Manal H. El‐Sayed

This figure shows the co-authorship network connecting the top 25 collaborators of Manal H. El‐Sayed. A scholar is included among the top collaborators of Manal H. El‐Sayed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manal H. El‐Sayed. Manal H. El‐Sayed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
El‐Sayed, Manal H., et al.. (2025). The impact of frailty on functional recovery after cardiac surgery—a case control study. Perioperative Medicine. 14(1). 46–46. 1 indexed citations
3.
4.
El‐Sayed, Manal H., et al.. (2024). Early topical mitomycin‐C prevents stricture formation in children with caustic ingestion. Journal of Paediatrics and Child Health. 60(9). 402–408. 1 indexed citations
5.
Hiebert, Lindsey, Catherine A. Chappell, Manal H. El‐Sayed, et al.. (2024). Best practices for hepatitis C linkage to care in pregnant and postpartum women: perspectives from the Treatment In Pregnancy for Hepatitis C Community of Practice. American Journal of Obstetrics and Gynecology. 231(4). 377–385. 2 indexed citations
6.
Howell, Jessica, Jack Wallace, Yinzong Xiao, et al.. (2023). Pathway to global elimination of hepatitis B: HBV cure is just the first step. Hepatology. 78(3). 976–990. 20 indexed citations
7.
Fofana, Djeneba, Anou M. Somboro, Mamoudou Maïga, et al.. (2023). Hepatitis B Virus in West African Children: Systematic Review and Meta-Analysis of HIV and Other Factors Associated with Hepatitis B Infection. International Journal of Environmental Research and Public Health. 20(5). 4142–4142. 8 indexed citations
8.
9.
Hassany, Mohamed, Wafaa Elakel, Mohamed AbdAllah, et al.. (2022). Seroprevalence of HBV/HCV coinfection among patients with HCV screened during the national campaign for HCV eradication in Egypt. Arab Journal of Gastroenterology. 23(4). 259–262. 3 indexed citations
10.
Said, Zeinab Nabil Ahmed & Manal H. El‐Sayed. (2022). Challenge of managing hepatitis B virus and hepatitis C virus infections in resource-limited settings. World Journal of Hepatology. 14(7). 1333–1343. 20 indexed citations
11.
El‐Kassas, Mohamed, Wafaa Elakel, Mohamed Alboraie, et al.. (2022). Egyptian revalidation of non-invasive parameters for predicting esophageal varices in cirrhotic patients: A retrospective study. Arab Journal of Gastroenterology. 23(2). 120–124.
12.
Farid, Samar, et al.. (2021). The potential hepatoprotective effect of metformin in hepatitis C virus‐infected adolescent patients with beta thalassemia major: Randomised clinical trial. International Journal of Clinical Practice. 75(6). e14104–e14104. 12 indexed citations
13.
Mostafa, Aya, Ossama Ashraf Ahmed, Hany Dabbous, et al.. (2021). The outcome of re-treatment of relapsed hepatitis C virus infection in a resource-limited setting. VirusDisease. 32(3). 582–588. 1 indexed citations
14.
Metwally, Ammal M., Lobna A. El Etreby, Marwa M. El-Sonbaty, et al.. (2021). Accelerating Hepatitis C virus elimination in Egypt by 2030: A national survey of communication for behavioral development as a modelling study. PLoS ONE. 16(2). e0242257–e0242257. 13 indexed citations
15.
Abdel‐Razek, Wael, Mohamed Hassany, Manal H. El‐Sayed, et al.. (2019). Hepatitis C Virus in Egypt: Interim Report From the World’s Largest National Program. Clinical Liver Disease. 14(6). 203–206. 18 indexed citations
16.
Scott, Nick, David P. Wilson, Alexander Thompson, et al.. (2019). The case for a universal hepatitis C vaccine to achieve hepatitis C elimination. BMC Medicine. 17(1). 175–175. 20 indexed citations
17.
Elbaz, Tamer, Magdy El‐Serafy, Wafaa Elakel, et al.. (2017). Serious Adverse Events with Sofosbuvir Combined with Interferon and Ribavirin: Real-Life Egyptian Experience. Journal of Interferon & Cytokine Research. 37(8). 348–353. 4 indexed citations
18.
El‐Beshlawy, Amal, et al.. (2008). Assessment of Puberty in Relation to L-carnitine and Hormonal Replacement Therapy in  -thalassemic Patients. Journal of Tropical Pediatrics. 54(6). 375–381. 9 indexed citations
19.
Zekri, Abdel‐Rahman N., et al.. (2007). Hepatitis B virus (HBV) genotypes in Egyptian pediatric cancer patients with acute and chronic active HBV infection. Virology Journal. 4(1). 74–74. 44 indexed citations
20.
Zekri, Abdel‐Rahman N., Waleed Mohamed, Mohamed Samra, et al.. (2004). Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation. Transplant Immunology. 13(4). 305–311. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher O’Brien Breakdown of academic impact, for papers by Silvia Gaiani Breakdown of academic impact, for papers by Andrew Jack Breakdown of academic impact, for papers by Amir Qamar Breakdown of academic impact, for papers by María E. Mayorga Breakdown of academic impact, for papers by David Krause Breakdown of academic impact, for papers by Johan Wallin Breakdown of academic impact, for papers by Giovanni Vizzini Breakdown of academic impact, for papers by Ashish Garg
Rankless by CCL
2026